Tiziana Life Sciences Ltd. Common Shares (TLSA)
Stock · NASDAQ · Health Care
$1.01as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
Resistance level
$1.36
Industry
Biotechnology: Pharmaceutical Preparations
About TLSA
Tiziana Life Sciences Ltd, together with its subsidiaries, engages in the research and development of therapies for neurodegenerative and neuroinflammatory diseases in the United Kingdom and internationally. It develops Foralumab TZLS-401, a human anti-CD3 monoclonal antibody, which is Phase II clinical trial for the treatment of non-active secondary progressive multiple sclerosis, Alzheimer's disease, multi system a…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 10
- Website
- www.tizianalifesciences.com
Fundamentals
- 1-day range
- $1.04$1.2
- Market cap
- $123.35M
- P/E (trailing)
- —
- P/E (forward)
- -5.69
- EPS (trailing)
- $-0.16
- Dividend yield
- —
- Beta
- 0.46
- Avg. volume
- 428.2K
52-week range
$0.87$2.35
Forecasts
1 analyst ratings
Buy 100%
Hold 0%
Sell 0%
1-year price forecast
High
$9.06
+797.1%
Median
$9.06
+797.1%
Low
$9.06
+797.1%
Tiziana Life Sciences Ltd. Common Shares Competitors
Chosen by industry and closest market cap.
- TLSATiziana Life Sciences Ltd. Common Shares$1.01▼ 6.48%Market cap $123.35MP/E —$0.87$2.35
- CNTBConnect Biopharma Holdings Limited Ordinary Shares$2.22▼ 2.63%Market cap $124.04MP/E —$1.23$3.82
- IFRXInflaRx N.V. Common Stock$2.22▼ 2.20%Market cap $126.51MP/E —$0.7984$2.95
- PMNProMIS Neurosciences Inc. Common Shares (ON)$13.79▼ 1.43%Market cap $126.80MP/E —$6.27$27.4
- VTVTvTv Therapeutics Inc. Class A Common Stock$32.17▼ 1.92%Market cap $127.58MP/E 55.59$15.79$44
- SPRBSpruce Biosciences Inc. Common Stock$60.05▼ 5.13%Market cap $118.73MP/E —$7$240
- BGMBGM Group Ltd. Class A Ordinary Shares$0.3251▲ 11.34%Market cap $116.58MP/E —$0.2287$11.8
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| TLSA Tiziana Life Sciences Ltd. Common Shares | $123.35M | — | $1.01 | ▼ 6.48% | $0.87$2.35 |
| CNTB Connect Biopharma Holdings Limited Ordinary Shares | $124.04M | — | $2.22 | ▼ 2.63% | $1.23$3.82 |
| IFRX InflaRx N.V. Common Stock | $126.51M | — | $2.22 | ▼ 2.20% | $0.7984$2.95 |
| PMN ProMIS Neurosciences Inc. Common Shares (ON) | $126.80M | — | $13.79 | ▼ 1.43% | $6.27$27.4 |
| VTVT vTv Therapeutics Inc. Class A Common Stock | $127.58M | 55.59 | $32.17 | ▼ 1.92% | $15.79$44 |
| SPRB Spruce Biosciences Inc. Common Stock | $118.73M | — | $60.05 | ▼ 5.13% | $7$240 |
| BGM BGM Group Ltd. Class A Ordinary Shares | $116.58M | — | $0.3251 | ▲ 11.34% | $0.2287$11.8 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Tiziana Life Sciences Says Imaging Results Show Neuroinflammation Reduction in Rare Neurodegenerative ConditionBenzinga · 7/31/2026
- Tiziana Life Sciences Announces Quantitative PET Imaging Results From Third Patient With Multiple System Atrophy In Its Phase 2 Clinical Trial Treated With Intranasal Foralumab To Complete Dosing; Scans Demonstrated Reductions In Inflammatory ActivityBenzinga · 7/31/2026
Insider Activity
Insider Actions →Acquired
1.05M
Disposed
0
- Ivor Elrifi · August 5, 2026 · Buy237.6K @ $1
- Ivor Elrifi · August 4, 2026 · Buy83.8K @ $0.97
- Ivor Elrifi · August 3, 2026 · Buy667.0K @ $1
- Gabriele M. Cerrone · July 21, 2026 · Grant42.4K @ $0.99
- Gabriele M. Cerrone · June 12, 2026 · Grant15.0K @ $1.11
See the full, filterable feed with live charts on the MarketWall dashboard.